Explore Leadership and Execution in Biotech Innovation
ExecMind Life Science Executive Search is pleased to announce its partnership with From Lab to Market, an event bringing together biotech and healthcare innovators, investors and industry experts to explore how promising scientific discoveries can become investment-ready, commercially viable businesses.
The event will take place on 29 October 2026, from 13:00 to 17:00, at Forum AstraZeneca in Warsaw, bringing together founders, scientists, venture capital investors, technology transfer professionals and Life Sciences industry leaders.
Great Science Needs Great Leadership
With over 11 years of experience supporting biotech and Life Sciences companies across Europe, ExecMind has seen taht scientific excellence alone does not guarantee commercial success.
Transforming innovative research into a successful company requires more than promising technology. It demands experienced leadership, strategic decision-making, access to industry networks and the ability to execute ambitious development plans.
The right leader, someone who understands the science, has navigated similar business challenges and knows how to build strategic partnerships can significantly influence a company's development and growth potential.
Putting Execution at the Centre of the Conversation
Karolina Jarosinska, Founder and Managing Director of ExecMind, will chair the World Café roundtable dedicated to execution, exploring one of the most critical challenges facing early-stage biotech and healthcare ventures: how to translate scientific potential and strategic ambitions into tangible business results.
The discussion will address the importance of leadership capabilities, organisational readiness and practical execution in advancing innovative projects towards investment, partnerships and commercialisation.
The programme also includes a lightning panel examining what makes a project truly investment-ready, followed by five interactive World Café roundtables covering:
- Science and market potential
- Investment readiness
- Regulatory risk
- Execution
- Evaluation biases
The event will provide an opportunity for meaningful exchanges between scientific innovators, investors, industry experts and ecosystem partners.
Join Us in Warsaw
ExecMind is delighted to support this initiative alongside WeBeam and Forum MedTech AstraZeneca, contributing its perspective on leadership, company building and the challenges of scaling innovation-driven Life Sciences businesses.
Event details
Date: 29 October 2026
Time: 13:00–17:00
Venue: Forum AstraZeneca, Warsaw
Admission: Free, with limited places
Registration: https://fromlabtomarket.webeam.io/
We look forward to meeting the biotech and healthcare innovation community in Warsaw and contributing to the discussion on what it takes to turn great science into successful companies.
